2075 related articles for article (PubMed ID: 8291613)
1. Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.
de Vries TJ; Quax PH; Denijn M; Verrijp KN; Verheijen JH; Verspaget HW; Weidle UH; Ruiter DJ; van Muijen GN
Am J Pathol; 1994 Jan; 144(1):70-81. PubMed ID: 8291613
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Hsp27 in a human melanoma cell line: regulation of E-cadherin, MUC18/MCAM, and plasminogen activator (PA) system.
Aldrian S; Kindas-Mügge I; Trautinger F; Fröhlich I; Gsur A; Herbacek I; Berger W; Micksche M
Cell Stress Chaperones; 2003; 8(3):249-57. PubMed ID: 14984058
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of the anti-tumor effect of actinomycin D by tumor necrosis factor alpha in mice: correlation between in vitro and in vivo results.
Lasek W; Giermasz A; Kuc K; Wańkowicz A; Feleszko W; Gołab J; Zagozdzon R; Stokłosa T; Jakóbisiak M
Int J Cancer; 1996 May; 66(3):374-9. PubMed ID: 8621260
[TBL] [Abstract][Full Text] [Related]
4. Beta-thujaplicin zinc chelate induces apoptosis in mouse high metastatic melanoma B16BL6 cells.
Miyamoto D; Endo N; Oku N; Arima Y; Suzuki T; Suzuki Y
Biol Pharm Bull; 1998 Dec; 21(12):1258-62. PubMed ID: 9881634
[TBL] [Abstract][Full Text] [Related]
5. Lack of p53 mutations and loss of heterozygosity in non-cultured human melanocytic lesions.
Papp T; Jafari M; Schiffmann D
J Cancer Res Clin Oncol; 1996; 122(9):541-8. PubMed ID: 8781568
[TBL] [Abstract][Full Text] [Related]
6. Overcoming the metastasis-enhancing potential of human tumor necrosis factor alpha by introducing the cell-adhesive Arg-Gly-Asp sequence.
Miyata K; Mitsuishi Y; Shikama H; Kuroda K; Nishimura K; Sakae N; Kato M
J Interferon Cytokine Res; 1995 Feb; 15(2):161-9. PubMed ID: 8590320
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of cutaneous nevocarcinomas].
Banzet P; Belaich S; Civatte J; Puissant A; Jacquillat C; Israel L
J Chir (Paris); 1976 Mar; 111(3):347-54. PubMed ID: 956292
[TBL] [Abstract][Full Text] [Related]
8. Cysteine proteinase inhibitors reduce malignant melanoma cell invasion in vitro.
Bjørnland K; Buø L; Kjønniksen I; Larsen M; Fodstad O; Johansen HT; Aasen AO
Anticancer Res; 1996; 16(4A):1627-31. PubMed ID: 8712680
[TBL] [Abstract][Full Text] [Related]
9. [Surgically treated malignant melanoma. The long-term results].
Meierovici D; Ceauşu M; Păun F
Chirurgia (Bucur); 1995; 44(4):69-71. PubMed ID: 8646029
[TBL] [Abstract][Full Text] [Related]
10. Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis.
Seftor RE; Seftor EA; De Larco JE; Kleiner DE; Leferson J; Stetler-Stevenson WG; McNamara TF; Golub LM; Hendrix MJ
Clin Exp Metastasis; 1998 Apr; 16(3):217-25. PubMed ID: 9568639
[TBL] [Abstract][Full Text] [Related]
11. Changing standards of surgical care for the melanoma patient.
Reintgen DS
Ann Surg Oncol; 1996 Jul; 3(4):327-8. PubMed ID: 8790843
[No Abstract] [Full Text] [Related]
12. The adjuvancy of silicones: dependency on compartmentalization.
Klykken PC; White KL
Curr Top Microbiol Immunol; 1996; 210():113-21. PubMed ID: 8565549
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous side effects associated with interleukin 2 administration for metastatic melanoma.
Wolkenstein P; Chosidow O; Wechsler J; Guillaume JC; Lescs MC; Brandely M; Avril MF; Revuz J
J Am Acad Dermatol; 1993 Jan; 28(1):66-70. PubMed ID: 8425972
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma.
Lissoni P; Brivio O; Brivio F; Barni S; Tancini G; Crippa D; Meregalli S
J Pineal Res; 1996 Nov; 21(4):239-42. PubMed ID: 8989723
[TBL] [Abstract][Full Text] [Related]
15. Objective malignancy grading: a review emphasizing unbiased stereology applied to breast tumors.
Ladekarl M
APMIS Suppl; 1998; 79():1-34. PubMed ID: 9645191
[TBL] [Abstract][Full Text] [Related]
16. X-ray microscopic visualization of specific labeling of adhesive molecule CD36 and cytoadherence by Plasmodium falciparum infected erythrocytes.
Yeung J; Brown JT; Nair A; Meites E; Coppel RL; Mohandas N; Meyer-Ilse W; Magowan C
Res Commun Mol Pathol Pharmacol; 1998 Mar; 99(3):245-58. PubMed ID: 9591321
[TBL] [Abstract][Full Text] [Related]
17. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.
Luca M; Huang S; Gershenwald JE; Singh RK; Reich R; Bar-Eli M
Am J Pathol; 1997 Oct; 151(4):1105-13. PubMed ID: 9327744
[TBL] [Abstract][Full Text] [Related]
18. Effect of IL-6 on tumor cell invasion of vascular endothelial monolayers.
Kitamura Y; Morita I; Nihei Z; Mishima Y; Murota S
Surg Today; 1997; 27(6):534-41. PubMed ID: 9306547
[TBL] [Abstract][Full Text] [Related]
19. Endothelial CD44H mediates adhesion of a melanoma cell line to quiescent human endothelial cells in vitro.
Price EA; Coombe DR; Murray JC
Int J Cancer; 1996 Feb; 65(4):513-8. PubMed ID: 8621236
[TBL] [Abstract][Full Text] [Related]
20. Familial melanoma.
Newton JA
Clin Exp Dermatol; 1993 Jan; 18(1):5-11. PubMed ID: 8440053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
